Tag: Cancer: Lung
AI Model Can Help Segment NSCLC Tumors on CT Images
Reduced segmentation time, interobserver variability seen with artificial intelligence assistance in segmentation for radiotherapy targeting
Pathogenic Germline Variants ID’d in Patients With Lung Cancer
About 15 percent of patients diagnosed with lung cancer had PGVs, most of which were potentially clinically actionable
Tabrecta Gains Full FDA Approval for Non-Small Cell Lung Cancer
Drug approved for non-small cell lung cancer with mutation leading to MET exon 14 skipping
Most Women With Lung Cancer Report Sexual Dysfunction
Little or no interest in sexual activity reported by majority of patients surveyed
Lung Cancer Risk Increased for Smokers Not Offered Annual Screening
Risk for incident lung cancer increased for current smokers and former smokers not recommended for annual low-dose CT screening
Myths, Ignorance Persist Around Lung Cancer: Poll
Only 29 percent of Americans know that lung cancer is the No. 1 cancer killer
Telemedicine Success Tied to Patient Outcomes in Thoracic Cancer
Sociodemographic disparities may make successful telemedicine visits less likely, leading to increased chances for poorer outcomes
More African-Americans Screened for Lung Cancer With USPSTF 2021 Criteria
Expanding lung cancer screening criteria is step toward greater equity for high-risk populations
Income, Education Linked to Advanced Stage of Diagnosis of NSCLC
Findings persist among race/ethnic groups, regardless of government or private insurance, and across facility types
ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
In phase 2 trial, overall survival longer with combo treatment compared with investigator's choice for standard of care in advanced NSCLC